545 related articles for article (PubMed ID: 26763280)
21. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction.
Murtagh G; Laffin LJ; Patel KV; Patel AV; Bonham CA; Yu Z; Addetia K; El-Hangouche N; Maffesanti F; Mor-Avi V; Hogarth DK; Sweiss NJ; Beshai JF; Lang RM; Patel AR
Echocardiography; 2016 Sep; 33(9):1344-52. PubMed ID: 27677642
[TBL] [Abstract][Full Text] [Related]
22. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA
Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
26. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.
Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871
[TBL] [Abstract][Full Text] [Related]
27. Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias.
Hasdemir C; Yuksel A; Camli D; Kartal Y; Simsek E; Musayev O; Isayev E; Aydin M; Can LH
Pacing Clin Electrophysiol; 2012 Apr; 35(4):465-70. PubMed ID: 22303908
[TBL] [Abstract][Full Text] [Related]
28. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction.
Kato S; Saito N; Kirigaya H; Gyotoku D; Iinuma N; Kusakawa Y; Iguchi K; Nakachi T; Fukui K; Futaki M; Iwasawa T; Taguri M; Kimura K; Umemura S
Int J Cardiol; 2015 Jul; 191():314-9. PubMed ID: 26005800
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
[TBL] [Abstract][Full Text] [Related]
31. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
[TBL] [Abstract][Full Text] [Related]
32. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
Pöyhönen P; Kivistö S; Holmström M; Hänninen H
BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
[TBL] [Abstract][Full Text] [Related]
33. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure.
Masci PG; Doulaptsis C; Bertella E; Del Torto A; Symons R; Pontone G; Barison A; Droogné W; Andreini D; Lorenzoni V; Gripari P; Mushtaq S; Emdin M; Bogaert J; Lombardi M
Circ Heart Fail; 2014 May; 7(3):448-56. PubMed ID: 24647118
[TBL] [Abstract][Full Text] [Related]
34. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis.
Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG
J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.
Gaztanaga J; Paruchuri V; Elias E; Wilner J; Islam S; Sawit S; Viles-Gonzalez J; Sanz J; Garcia MJ
Am J Cardiol; 2016 Oct; 118(7):1063-8. PubMed ID: 27614850
[TBL] [Abstract][Full Text] [Related]
36. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T
J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955
[TBL] [Abstract][Full Text] [Related]
37. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death.
Nadel J; Lancefield T; Voskoboinik A; Taylor AJ
Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):634-41. PubMed ID: 25617029
[TBL] [Abstract][Full Text] [Related]
38. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.
Cain MA; Metzl MD; Patel AR; Addetia K; Spencer KT; Sweiss NJ; Beshai JF
Am J Cardiol; 2014 May; 113(9):1556-60. PubMed ID: 24731652
[TBL] [Abstract][Full Text] [Related]
39. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
